Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Xiying Shao PhD"'
Publikováno v:
Technology in Cancer Research & Treatment, Vol 22 (2023)
Recent studies have demonstrated that the combination of Cyclin-Dependent Kinase 4/6 Inhibitor (CDK4/6i) and endocrine therapy (ET) is more effective than ET alone and significantly improves progression-free survival (PFS) and overall survival (OS) i
Externí odkaz:
https://doaj.org/article/2c1b4db33d4f456687a10115ba65d1eb
